CTNND1 and pancreatic neoplasm: Predicted to be targeted by miR409, Catenin Delta 1 (CTNND1) along with Catenin alpha 1 (CTNNA1) and Catenin Beta 1 (CTNNB1) expression was shown to indicate a poor prognosis for pancreatic cancer patients [75].